XBiotech Inc.
XBIT
$2.75
-$0.07-2.48%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.00M | 1.93M | 927.00K | 777.00K | 1.98M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.34M | 13.55M | 8.75M | 7.90M | 14.97M |
| Operating Income | -6.34M | -13.55M | -8.75M | -7.90M | -14.97M |
| Income Before Tax | -1.73M | -10.86M | -10.55M | -5.01M | -13.03M |
| Income Tax Expenses | 28.00K | 29.00K | -41.00K | 9.00K | -25.00K |
| Earnings from Continuing Operations | -1.76M | -10.88M | -10.51M | -5.02M | -13.01M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.76M | -10.88M | -10.51M | -5.02M | -13.01M |
| EBIT | -6.34M | -13.55M | -8.75M | -7.90M | -14.97M |
| EBITDA | -5.90M | -13.11M | -8.31M | -7.47M | -14.53M |
| EPS Basic | -0.06 | -0.36 | -0.34 | -0.16 | -0.43 |
| Normalized Basic EPS | -0.04 | -0.22 | -0.22 | -0.10 | -0.27 |
| EPS Diluted | -0.06 | -0.36 | -0.34 | -0.16 | -0.43 |
| Normalized Diluted EPS | -0.04 | -0.22 | -0.22 | -0.10 | -0.27 |
| Average Basic Shares Outstanding | 30.49M | 30.49M | 30.47M | 30.47M | 30.46M |
| Average Diluted Shares Outstanding | 30.49M | 30.49M | 30.47M | 30.47M | 30.46M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |